The Asia-Pacific region represents many opportunities for sponsors. The region has seen a significant growth in the number and size of clinical trials in the past decade. However, despite this growth, there remains some misconceptions about running clinical trials in what is widely considered the most dynamic region on Earth.
How can sponsors make the most of this constantly evolving landscape?
In recognition of Kidney Week, world-renowned renal physician-researcher, Professor Vlado Perkovic, who has over twenty years’ experience conducting trials in the Asia-Pacific region, will discuss the current state of clinical trial development and practice in the area; and where the sector may be heading in the future.
Professor Perkovic, who is currently Executive Director of The George Institute, Australia, and sits on the editorial board of several leading journals including the New England Journal of Medicine, will provide a thorough examination of the current status of trials in kidney disease, and future directions. He will also provide insights into the Asia-Pacific region, outlining the region’s opportunities and addressing any common misconceptions, all through the lens of renal trials. It is worth noting that despite his therapy area expertise, this webinar will be relevant to all sponsors interested in the region, regardless of their therapy area focus.
Professor Vlado Perkovic, Executive Director, The George Institute, Australia
Vlado Perkovic is Executive Director of The George Institute, Australia, Professor of Medicine at UNSW Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital.
His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several international clinical trials and has been involved in developing Australian and global treatment guidelines. He has played a central role in the development of an affordable dialysis system, which was a Eureka Prize finalist in 2017.
Vlado is a member of the National Health and Medical Research Council Principal Committee on Research Translation, and is on the Board of the Australian Clinical Trials Alliance and the Association of Australian Medical Research Institutes. He is Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, and the Australian Academy of Health and Medical Sciences. He serves on the Editorial Boards of a number of leading specialist and general journals, including the Journal of the American Society of Nephrology, Circulation, and the New England Journal of Medicine.
Who Should Attend?
This webinar will benefit those working in the following industries:
- Medical Device Companies
- Device, Diagnostic, or Equipment
- Drug Development/Clinical Trials Consulting
- Information Technology
- Trial/Site Management
Relevant job titles include:
- ‘C’ Level Executives
- Account Management, including Supervisors and Executives
- Clinical Monitoring/Investigative Site Management
- Clinical Trial Management
- Corporate Management
- Information Technology Management
- Business Development
- R&D/Project Management
- Marketing Management
- Marketing Research
- Media/Promotion Management
- Product Management
What You Will Learn
In this webinar, Professor Perkovic will:
- Outline the current state of clinical trials in the Asia-Pacific
- Define the reasons for growth and clarify potential misconceptions about conducting clinical trials in the region
- Address the benefits and the hurdles of conducting clinical trials in the Asia-Pacific
- Provide insights into how and where he sees the clinical trial landscape developing into the future
George Clinical is a leading independent clinical research organization (CRO) with global capabilities. With staff operating in 16 countries, George Clinical provides the full range of clinical trial services to pharmaceutical, medical device, and biotech customers, for all trial phases, registration, and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, bringing together an extensive series of investigator networks that allow George Clinical to provide customizable clinical trial excellence from trial design through all aspects of delivery.